Thalidomide: Near complete regression of extramedullary bulk in refractory multiple myeloma

Swiss Medical Weekly

Volumn 131, Issue 9-10, 2001, Pages 133-

  Trojan, A ^a   Anagnostara, A ^a   Jost, L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; CANCER REGRESSION; CASE REPORT; DRUG EFFECT; HUMAN; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; REVIEW; SPINAL CORD COMPRESSION;

EID: 0035099565     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. Antitumor activity of thalidomide in refractory multiple myeloma
2. Continuous low dose thalidomide: A phase 11 study in advanced melanoma, renal cell, ovarian and breast cancer
3. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma
4. Phase 11 evaluation of thalidomide in patients with metastatic breast cancer